Esperion Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	332.31	116.33	75.48	78.45	227.55	Upgrade
Revenue Growth (YoY)	185.66%	54.14%	-3.79%	-65.53%	53.37%	Upgrade
Cost of Revenue	114.84	129.37	145.89	120.19	149.33	Upgrade
Gross Profit	217.48	-13.04	-70.42	-41.75	78.22	Upgrade
Selling, General & Admin	163.07	142.52	109.08	171.74	199.62	Upgrade
Operating Expenses	163.07	142.52	109.08	171.74	199.62	Upgrade
Operating Income	54.4	-155.56	-179.5	-213.48	-121.4	Upgrade
Interest Expense	-59.25	-58.98	-56.81	-46.35	-22.67	Upgrade
Interest & Investment Income	7.6	4.4	2.4	0.1	0.5	Upgrade
Other Non Operating Income (Expenses)	0.42	0.48	0.53	1.24	-0.08	Upgrade
EBT Excluding Unusual Items	3.17	-209.66	-233.38	-258.49	-143.65	Upgrade
Gain (Loss) on Sale of Investments	-	0.41	-0.28	-0.01	0.1	Upgrade
Legal Settlements	-	-	-	-18.25	-	Upgrade
Other Unusual Items	-54.92	-	-	2.65	-	Upgrade
Pretax Income	-51.75	-209.25	-233.66	-269.11	-143.55	Upgrade
Net Income	-51.75	-209.25	-233.66	-269.11	-143.55	Upgrade
Net Income to Common	-51.75	-209.25	-233.66	-269.11	-143.55	Upgrade
Shares Outstanding (Basic)	187	103	66	29	27	Upgrade
Shares Outstanding (Diluted)	187	103	66	29	27	Upgrade
Shares Change (YoY)	81.54%	55.26%	129.76%	5.20%	1.42%	Upgrade
EPS (Basic)	-0.28	-2.03	-3.52	-9.31	-5.22	Upgrade
EPS (Diluted)	-0.28	-2.03	-3.52	-9.31	-5.22	Upgrade
Free Cash Flow	-23.97	-135.49	-174.83	-263.81	-86.05	Upgrade
Free Cash Flow Per Share	-0.13	-1.31	-2.63	-9.13	-3.13	Upgrade
Gross Margin	65.44%	-11.21%	-93.30%	-53.21%	34.38%	Upgrade
Operating Margin	16.37%	-133.72%	-237.83%	-272.13%	-53.35%	Upgrade
Profit Margin	-15.57%	-179.87%	-309.58%	-343.04%	-63.09%	Upgrade
Free Cash Flow Margin	-7.21%	-116.46%	-231.64%	-336.29%	-37.81%	Upgrade
EBITDA	54.47	-155.4	-179	-212.87	-120.85	Upgrade
EBITDA Margin	16.39%	-133.58%	-237.17%	-271.35%	-53.11%	Upgrade
D&A For EBITDA	0.06	0.16	0.5	0.61	0.55	Upgrade
EBIT	54.4	-155.56	-179.5	-213.48	-121.4	Upgrade
EBIT Margin	16.37%	-133.72%	-237.83%	-272.13%	-53.35%	Upgrade
Revenue as Reported	332.31	116.33	75.48	78.45	227.55	Upgrade
Advertising Expenses	25.5	15.6	11.3	13.7	19.3	Upgrade

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q